Meta appoints Arun Srinivas as its India head-February 2024-www.financetom.com

Meta appoints Arun Srinivas as its India head

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Meta appoints Arun Srinivas as its India head

Jun 15, 2025 10:30 PM

June 16 (Reuters) - Meta Platforms ( META ) on Monday

said Arun Srinivas has been appointed as the managing director

and head for Meta in India.

(Reporting by Rishabh Jaiswal in Bengaluru)

Previous page： TriSalus Life Sciences, Geo-Med Partner to Expand TriNav Infusion System Access in VA Medical Centers Next page： GoldMining Up 2.6% In US Premarket As Reports Additional High-Grade Drilling Results and Identified Multiple Drill Targets, Sao Jorge Project, Brazil

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

TriSalus Life Sciences, Geo-Med Partner to Expand TriNav Infusion System Access in VA Medical Centers

Nov 11, 2024

07:36 AM EST, 11/11/2024 (MT Newswires) -- TriSalus Life Sciences ( TLSI ) said Monday that it has partnered with Geo-Med, a certified service-disabled veteran-owned small business, to expand the availability of its TriNav Infusion System across US Department of Veterans Affairs medical centers. The company said Geo-Med is a key supplier to the Veterans Affairs and the US Department...

GoldMining Up 2.6% In US Premarket As Reports Additional High-Grade Drilling Results and Identified Multiple Drill Targets, Sao Jorge Project, Brazil

Nov 11, 2024

07:36 AM EST, 11/11/2024 (MT Newswires) -- GoldMining Inc. ( GLDG ) was at last look up 2.6% in US premarket trade -- it was even higher -- as the company reported Monday additional assay results from the 2024 auger drilling program at its 100% owned Sao Jorge Project in the Tapajos gold district, Para State, Brazil. Among highlights, it...

Can-Fite BioPharma Doses First Patient in Namodenoson Phase 2a Trial in Pancreatic Cancer

Nov 11, 2024

07:33 AM EST, 11/11/2024 (MT Newswires) -- Can-Fite BioPharma ( CANF ) said Monday that the first patient has been dosed in its phase 2a trial of Namodenoson in patients with advanced pancreatic adenocarcinoma. The company said it targets to enroll about 20 evaluable patients in the trial. The study's primary objective is to characterize Namodenoson's safety profile, while the...

Cigna says it will not pursue combination with Humana

Nov 11, 2024

Nov 11 (Reuters) - Health insurer Cigna Group ( CI ) said on Monday it is not pursuing a combination with peer Humana . ...